BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 21912937)

  • 1. Glioma residual or recurrence versus radiation necrosis: accuracy of pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT compared to proton magnetic resonance spectroscopy (1H-MRS): initial results.
    Amin A; Moustafa H; Ahmed E; El-Toukhy M
    J Neurooncol; 2012 Feb; 106(3):579-87. PubMed ID: 21912937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of 99mTc-MIBI brain SPECT and proton magnetic resonance spectroscopy (1H-MRS) to assess glioma recurrence after radiotherapy.
    Palumbo B; Lupattelli M; Pelliccioli GP; Chiarini P; Moschini TO; Palumbo I; Siepi D; Buoncristiani P; Nardi M; Giovenali P; Palumbo R
    Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):88-93. PubMed ID: 16557208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT: does it have a place in predicting survival in patients with glioblastoma multiforme?
    Amin A; Mustafa M; Abd El-Hadi E; Monier A; Badwey A; Saad E
    J Neurooncol; 2015 Jan; 121(2):303-9. PubMed ID: 25349131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Posttherapy technetium-99m pentavalent dimercaptosuccinic acid brain single-photon emission computed tomography/computed tomography: diagnostic and prognostic values in patients with glioma.
    Mohamadien NRA; Diab WA; Abd El-Ghani WMA; Abdelhafez YG
    Nucl Med Commun; 2022 Dec; 43(12):1195-1203. PubMed ID: 36345764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Tc-99m (V) DMSA scintigraphy in the diagnosis and follow-up of lung cancer lesions.
    Ergün EL; Kara PO; Gedik GK; Kars A; Türker A; Caner B
    Ann Nucl Med; 2007 Jul; 21(5):275-83. PubMed ID: 17634845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [
    Rani N; Singh B; Kumar N; Singh P; Hazari PP; Vyas S; Hooda M; Chitkara A; Shekhawat AS; Gupta SK; Radotra BD; Mishra AK
    Cancer Biother Radiopharm; 2021 Sep; 36(7):568-578. PubMed ID: 32644819
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison between contrast-enhanced magnetic resonance imaging and technetium 99m glucohepatonic acid single photon emission computed tomography with histopathologic correlation in gliomas.
    Kumar RA; Khandelwal N; Sodhi KS; Pathak A; Mittal BR; Radotra BD; Suri S
    J Comput Assist Tomogr; 2006; 30(5):723-33. PubMed ID: 16954918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pentavalent technetium-99m dimercaptosuccinic acid [99m Tc-(V)DMSA] brain scintitomography--a plausible non-invasive depicter of glioblastoma proliferation and therapy response.
    Tsiouris S; Pirmettis I; Chatzipanagiotou T; Ptohis N; Papantoniou V
    J Neurooncol; 2007 Dec; 85(3):291-5. PubMed ID: 17554495
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential diagnosis between radiation necrosis and glioma progression using sequential proton magnetic resonance spectroscopy and methionine positron emission tomography.
    Nakajima T; Kumabe T; Kanamori M; Saito R; Tashiro M; Watanabe M; Tominaga T
    Neurol Med Chir (Tokyo); 2009 Sep; 49(9):394-401. PubMed ID: 19779283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Technetium-99m sestamibi brain SPECT in the follow-up of glioma for evaluation of response to chemotherapy: first results.
    Prigent-Le Jeune F; Dubois F; Perez S; Blond S; Steinling M
    Eur J Nucl Med Mol Imaging; 2004 May; 31(5):714-9. PubMed ID: 14985865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.
    Zeng QS; Li CF; Zhang K; Liu H; Kang XS; Zhen JH
    J Neurooncol; 2007 Aug; 84(1):63-9. PubMed ID: 17619225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of diffusion tensor, dynamic susceptibility contrast MRI and (99m)Tc-Tetrofosmin brain SPECT for the detection of recurrent high-grade glioma.
    Alexiou GA; Zikou A; Tsiouris S; Goussia A; Kosta P; Papadopoulos A; Voulgaris S; Tsekeris P; Kyritsis AP; Fotopoulos AD; Argyropoulou MI
    Magn Reson Imaging; 2014 Sep; 32(7):854-9. PubMed ID: 24848292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating histologic malignancy of primary brain tumors: pentavalent technetium-99m-DMSA.
    Hirano T; Otake H; Shibasaki T; Tamura M; Endo K
    J Nucl Med; 1997 Jan; 38(1):20-6. PubMed ID: 8998143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Technetium-99m(V)-DMSA and thallium-201 in brain tumor imaging: correlation with histology and malignant grade.
    Hirano T; Otake H; Kazama K; Wakabayashi K; Zama A; Shibasaki T; Tamura M; Endo K
    J Nucl Med; 1997 Nov; 38(11):1741-9. PubMed ID: 9374344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (99m)Technetium pentavalent dimercaptosuccinic acid scintigraphy in the follow-up of clinically nonfunctioning pituitary adenomas after radiotherapy.
    Colao A; Ferone D; Lombardi G; Lastoria S
    Clin Endocrinol (Oxf); 2002 Jun; 56(6):713-21. PubMed ID: 12072040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. (99m)Tc-DTPA dynamic SPECT and CT volumetry for measuring split renal function in live kidney donors.
    Miyazaki C; Harada H; Shuke N; Okizaki A; Miura M; Hirano T
    Ann Nucl Med; 2010 Apr; 24(3):189-95. PubMed ID: 20213340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of brain tumor recurrence by (99m)Tc-tetrofosmin SPECT: a prospective pilot study.
    Alexiou GA; Fotopoulos AD; Papadopoulos A; Kyritsis AP; Polyzoidis KS; Tsiouris S
    Ann Nucl Med; 2007 Jul; 21(5):293-8. PubMed ID: 17634847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study.
    Plotkin M; Eisenacher J; Bruhn H; Wurm R; Michel R; Stockhammer F; Feussner A; Dudeck O; Wust P; Felix R; Amthauer H
    J Neurooncol; 2004 Oct; 70(1):49-58. PubMed ID: 15527107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring glioma growth and tumor necrosis with the U-SPECT-II/CT scanner by targeting integrin αvβ3.
    Shao G; Zhou Y; Wang F; Liu S
    Mol Imaging; 2013; 12(1):39-48. PubMed ID: 23348790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection.
    Zhang J; Zhuang DX; Yao CJ; Lin CP; Wang TL; Qin ZY; Wu JS
    J Neurosurg; 2016 Jun; 124(6):1585-93. PubMed ID: 26636387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.